Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bushnell, C. D.
Right arrow Articles by Goldstein, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bushnell, C. D.
Right arrow Articles by Goldstein, L. B.
Related Collections
Right arrow Hematologic
Right arrow All Cerebrovascular disease/Stroke
Right arrow Infarction
Neurology 2001;57:1333-1335
© 2001 American Academy of Neurology
Brief Communications

Improving patient selection for coagulopathy testing in the setting of acute ischemic stroke

Cheryl D. Bushnell, MD, Zaeem Siddiqi, MD PhD and Larry B. Goldstein, MD

From the Duke University Center for Cerebrovascular Disease (Drs. Bush-nell, Siddiqi, and Goldstein), Center for Clinical Health Policy Research (Dr. Goldstein), and Durham VA Medical Center (Dr. Goldstein), Durham, NC.

Address correspondence and reprint requests to Dr. Cheryl D. Bushnell, Duke University Medical Center, Box 2900, Durham, NC 27710; e-mail bushn002{at}mc.duke.edu

To improve patient selection for specialized coagulation testing in the setting of ischemic stroke, the authors sought to identify factors associated with the presence of hypercoagulable states. Of 208 patients with ischemic stroke tested, undetermined stroke subtype was significantly associated with the presence of coagulopathy, but only 60% were treated with warfarin. The frequency of coagulopathy in selected patients with ischemic stroke (5%) is low, and establishing the diagnosis did not uniformly influence treatment.




This article has been cited by other articles:


Home page
 StrokeHome page
C. D. Bushnell and L. B. Goldstein
Physician Knowledge and Practices in the Evaluation of Coagulopathies in Stroke Patients
Stroke, April 1, 2002; 33(4): 948 - 953.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by AAN Enterprises, Inc.